Identification of potential serum markers for endometrial cancer using protein expression profiling

[1] Amant F(2006)Endometrial cancer Lancet 366 491-505

[2] Moerman P(2007)The association between lipid profiles and breast cancer among Taiwanese women Clin Chem Lab Med 45 1219-1223

[3] Neven P(1999)The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma Eur J Gynaecol Oncol 20 315-317

[4] Timmerman D(2002)Inflammation and cancer Nature 420 860-867

[5] Van Limbergen E(2007)Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling Pancreas 34 205-214

[6] Vergote I(2002)Clinical usefulness of color Doppler ultrasound in patients with endometrial hyperplasia and carcinoma Cancer 94 700-706

[7] Chang SJ(1995)Shroyer KR (1995) Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado Am J Clin Pathol 103 224-230

[8] Hou MF(2005)Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas Virchows Arch 447 816-822

[9] Tsai SM(2004)Serum tumor markers in the management of ovarian, endometrial and cervical cancer Biomed Pharmacother 58 24-38

[10] Wu SH(2005)Serum lipids concentration in women with benign and malignant ovarian tumours Eur J Obstet Gynecol Reprod Biol 120 87-90

[1] Amant F(2006)Endometrial cancer Lancet 366 491-505

[2] Moerman P(2007)The association between lipid profiles and breast cancer among Taiwanese women Clin Chem Lab Med 45 1219-1223

[3] Neven P(1999)The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma Eur J Gynaecol Oncol 20 315-317

[4] Timmerman D(2002)Inflammation and cancer Nature 420 860-867

[5] Van Limbergen E(2007)Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling Pancreas 34 205-214

[6] Vergote I(2002)Clinical usefulness of color Doppler ultrasound in patients with endometrial hyperplasia and carcinoma Cancer 94 700-706

[7] Chang SJ(1995)Shroyer KR (1995) Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado Am J Clin Pathol 103 224-230

[8] Hou MF(2005)Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas Virchows Arch 447 816-822

[9] Tsai SM(2004)Serum tumor markers in the management of ovarian, endometrial and cervical cancer Biomed Pharmacother 58 24-38

[10] Wu SH(2005)Serum lipids concentration in women with benign and malignant ovarian tumours Eur J Obstet Gynecol Reprod Biol 120 87-90